A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia: Southwest Oncology Group Study

✍ Scribed by Chatchada Karanes; Kenneth J Kopecky; David R Head; Michael R Grever; Harry E Hynes; Eric H Kraut; Richard H Vial; Alan Lichtin; Sucha Nand; Wolfram E Samlowski; Frederick R Appelbaum

• Book ID: 114119642
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 109 KB
• Volume: 23
• Category: Article
• ISSN: 0145-2126
• DOI: 10.1016/s0145-2126(99)00087-9